Trial intelligence / Profile preview

Afolia vs US Gonal-f PK Equivalence Study

NCT02459418Phase 1Completed

Sponsor
Fertility Biotech
Start
May 2015
Primary completion
May 2016
Countries
1
01

Overview

Phase 1, randomised, open-label trial of follitropin alfa in infertility (2 arms), sponsored by Fertility Biotech. Primary endpoints: Baseline Corrected FSH Area Under the Serum Concentration-time Curve From Zero to the Last Quantifiable Measurement at 192 hours and Baseline Corrected FSH Maximum Serum Concentration at 192 hours. Started May 2015; status: completed.

02

Drugs

follitropin alfa
03

Conditions

infertility

Beyond the preview

Go deeper on NCT02459418.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02459418.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call